Hoya (7741.T) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $55.18B | Exchange | JPX |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | JP | CEO | Eiichiro Ikeda |
| IPO Date | 2001-01-01 | CAGR | 6.14% |
| Employees | 37,752 | Website | www.hoya.com |
| Div. Yield | 0.67% | Payout Ratio | 37% |
| Buy Back Yield | 1.39% | Total Yield | 2.06% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $54.67B | P/E | 33.59 | Forward P/E | — | PEG | 1.18 |
| P/S | 14.69 | P/B | 14.2 | P/CF | 49.73 | P/FCF | 61.14 |
| Sales | $6.25B | Sales 1Y | 12.65% | Sales 3Y | 35.47% | Sales 5Y | 64.78% |
| EPS | $4.91 | EPS 1Y | 32.12% | EPS 3Y | 77.83% | EPS 5Y | 109.28% |
| Sales QoQ | 3.07% | EPS QoQ | 22.07% | Sales QoQ Avg | 3.8% | EPS QoQ Avg | 13.93% |
| Gross Margin | 78.9% | Operating Margin | 30.18% | Profit Margin | 27.16% | ROCE | 26.77% |
| ROA | 21% | ROE | 26% | Altman Z Score | 21.47 | Piotroski Score | 6 |
| Current Ratio | 4.91 | Quick Ratio | 4.2 | Cash Ratio | 2.87 | Op. CF Ratio | 0.38 |
| Debt/Equity | 0.04 | Debt/Assets | 0.03 | Lt Debt/Equity | 0.03 | Lt Debt/Cap. | 0.03 |
| Intrst Cov. | 150.9 | Inventory Turnover | 1.52 | Asset Turnover | 0.76 | Receivables Turnover | 4.57 |
| Enterprise Value | $54.67B | P/E Ratio | 33.59 |
| Forward P/E | — | PEG Ratio | 1.18 |
| P/S Ratio | 14.69 | P/B Ratio | 14.2 |
| P/CF Ratio | 49.73 | P/FCF Ratio | 61.14 |
| EPS | $4.91 | EPS Growth 1Y | 32.12% |
| EPS Growth 3Y | 77.83% | EPS Growth 5Y | 109.28% |
| Revenue Growth 1Y | 12.65% | Gross Margin | 0.79% |
| Operating Margin | 0.3% | Profit Margin | 0.27% |
| ROE | 0.26% | ROA | 0.21% |
| ROCE | 0.27% | Current Ratio | 4.91 |
| Quick Ratio | 4.2 | Cash Ratio | 2.87 |
| Debt/Equity | 0.04 | Interest Coverage | 150.9 |
| Altman Z Score | 21.47 | Piotroski Score | 6 |
Hoya (7741.T) valuation & financials
Hoya (7741.T) has a market capitalization of 55.18B JPY and trades at a price-to-earnings ratio of 33.6. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Hoya's revenue grew +12.7% over the last year.
Hoya's next earnings report is scheduled for October 29, 2026; analysts estimate EPS of 1.22 JPY. Check the earnings calendar to see all companies reporting this week.
Hoya (7741.T) — frequently asked questions
When does Hoya (7741.T) report earnings next?
Hoya is expected to report earnings on October 29, 2026. Analysts estimate EPS of 1.22 JPY.
What is Hoya's market cap?
Hoya (7741.T) has a market capitalization of 55.18B JPY.
What is 7741.T's P/E ratio?
Hoya trades at a price-to-earnings ratio of 33.6, with trailing twelve-month EPS of 4.91 JPY.
How fast is Hoya growing?
Hoya's revenue grew +12.7% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)